Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Apr 01 2025

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-01-2025-16

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial)".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases